Powder: -20°C for 3 years | In solvent: -80°C for 1 year
IGS-1.76 exhibits pronounced affinity towards hNCS-1 and effectively modulates the interaction between hNCS-1 and Ric8a. Moreover, IGS-1.76 proficiently inhibits the complex formed by human NCS-1 and Ric8a.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 98.00 | |
5 mg | In stock | $ 249.00 | |
10 mg | In stock | $ 416.00 | |
25 mg | In stock | $ 692.00 | |
50 mg | In stock | $ 985.00 | |
100 mg | In stock | $ 1,330.00 | |
500 mg | In stock | $ 2,660.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 273.00 |
Description | IGS-1.76 exhibits pronounced affinity towards hNCS-1 and effectively modulates the interaction between hNCS-1 and Ric8a. Moreover, IGS-1.76 proficiently inhibits the complex formed by human NCS-1 and Ric8a. |
Targets&IC50 | TRPC3:0.49 uM |
In vitro | IGS-1.76, which efficiently inhibits the human NCS-1/Ric8a complex with improved binding potency. |
Molecular Weight | 358.46 |
Formula | C22H18N2OS |
CAS No. | 313480-47-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 22.5 mg/mL (62.77 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
IGS-1.76 313480-47-6 Others NCS-1 Ric8a IGS 1.76 PPI inhibit IGS1.76 Inhibitor inhibitor